Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 2c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $5.9 million versus the consensus estimate of $6.02 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• AXIL Brands (AXIL) Tops Q4 EPS by 4c